Oncology

Resources

Tailoring Research and Test Development to Reduce Mortality Risk of Endometrial Cancer

Tailoring Research and Test Development to Reduce Mortality Risk of Endometrial CancerEndometrial cancer (EC) is the most common gynecologic malignancy in the United States and in many other developed countries. Women with EC detected at an early stage have a higher likelihood of being cured of their cancer. A recent study by Mayo Clinic researchers, published in Gynecologic Oncology, aims to demonstrate the feasibility of detecting EC by combining minimally invasive specimen collection techniques with sensitive molecular testing.

Read this story

Refining Individualized Medicine: Study Reduces Time to Deliver Treatment Plan for Melanoma Patients

Refining Individualized Medicine: Study Reduces Time to Deliver Treatment Plan for Melanoma PatientsWith the emergence of individualized medicineā€”treating a person as an individual and tailoring health care specific to that patientā€”developments in precision diagnostics are a critical driving force, especially via molecular testing. A recent study by Mayo Clinic researchers, published in the journal Human Pathology, aims to design and implement a scalable process that permits pre-appointment BRAF/KIT mutation analysis in melanoma patients.

Read this story

Evaluating Renal Cell Carcinoma Surveillance Guidelines

Evaluating Renal Cell Carcinoma Surveillance GuidelinesThe National Comprehensive Cancer Network (NCCN) and American Urological Association (AUA) provide guidelines for surveillance after surgery for renal cell carcinoma (RCC). In a recent study in the Journal of Clinical Oncology, Mayo Clinic researchers assess the ability of the guidelines to capture RCC recurrences after surgery when abiding by the prescribed protocols.

Read this story

Additional Resources

View all oncology resources


Key